Ultrafiltration for Kidney Failure

(DRIVE-UF Trial)

This trial tests whether extra ultrafiltration treatments can help dialysis patients by removing excess fluid from their bodies. The goal is to determine if reducing this fluid improves symptoms and blood pressure. Ultrafiltration, a type of dialysis, focuses on fluid removal without blood cleaning. Participants will either continue with regular dialysis or receive additional ultrafiltration for 4 or 8 weeks. Ideal candidates are those currently on dialysis for kidney disease who have high blood pressure despite multiple medications or experience symptoms of fluid overload. As an unphased trial, this study offers an opportunity to explore new methods for improving health and managing symptoms.

Research has shown that ultrafiltration, a dialysis method for removing excess fluid, can pose safety concerns. Faster ultrafiltration rates, which refer to how quickly fluid is removed, are linked to higher health risks, including increased mortality, particularly for patients who regularly undergo hemodialysis. Studies have found that rates exceeding 10-13 mL/kg/h lead to more heart-related problems and lower survival rates.

Researchers are excited about ultrafiltration for kidney failure because it offers a unique approach compared to standard hemodialysis, which is typically performed thrice weekly. Ultrafiltration specifically targets excess fluid removal without the extensive filtering of blood, potentially leading to better fluid management and blood pressure control. This trial is exploring ultrafiltration combined with the careful tapering of blood pressure medications, which may enhance patient outcomes by reducing the strain on the heart and kidneys more effectively than traditional methods alone. The two different durations being tested—4 weeks and 8 weeks—could reveal optimal treatment lengths for maximizing benefits and minimizing side effects.

Research has shown that ultrafiltration effectively removes extra fluid in patients with kidney failure. Unlike traditional dialysis, which also cleans the blood, this method focuses solely on fluid removal. In this trial, some participants will receive ultrafiltration treatments for up to 4 weeks, while others will receive them for up to 8 weeks. Studies have found that eliminating excess fluid with ultrafiltration can better control blood pressure and reduce stress on the heart and lungs. By targeting fluid buildup, ultrafiltration may lessen symptoms and reduce hospital visits for those on dialysis. Early findings suggest it could offer a gentler way to manage fluid-related issues in kidney disease, with lasting benefits.⁶⁷⁸⁹¹⁰